We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$20.7M
Cap. Flow
+$5.39M
Cap. Flow %
1.83%
Top 10 Hldgs %
28.09%
Holding
92
New
25
Increased
25
Reduced
19
Closed
18

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$4.59M
2
ZTS icon
Zoetis
ZTS
+$4.07M
3
TMO icon
Thermo Fisher Scientific
TMO
+$3.62M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.97M
5
SYK icon
Stryker
SYK
+$2.87M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$9.28M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.79M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.91M
4
MRK icon
Merck
MRK
+$4.77M
5
CAH icon
Cardinal Health
CAH
+$3.9M

Sector Composition

Rank Sector Weight
1 Healthcare 86.68%
2 Financials 2.98%
3 Energy 1.23%
4 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
26
Acadia Pharmaceuticals
ACAD
$5.06B
$4.52M 1.54%
120,000
+65,000
+118% +$2.11M
SNN icon
27
Smith & Nephew
SNN
$12.6B
$4.37M 1.49%
120,000
+30,000
+33% +$1.07M
VAR
28
DELISTED
Varian Medical Systems, Inc.
VAR
$4.17M 1.42%
41,683
+16,683
+67% +$1.71M
ZTS icon
29
Zoetis
ZTS
$30.9B
$4.14M 1.41%
+65,000
New +$4.07M
MCK icon
30
McKesson
MCK
$103B
$3.84M 1.31%
25,000
-5,000
-17% -$780K
HRC
31
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.7M 1.26%
50,000
+10,000
+25% +$770K
LHCG
32
DELISTED
LHC Group LLC
LHCG
$3.61M 1.23%
50,910
+5,910
+13% +$379K
ISRG icon
33
Intuitive Surgical
ISRG
$139B
$3.4M 1.16%
29,250
– –
IPXL
34
DELISTED
Impax Laboratories, Inc.
IPXL
$3.35M 1.14%
165,000
-85,000
-34% -$1.62M
COR icon
35
Cencora
COR
$62B
$3.31M 1.13%
40,000
-15,000
-27% -$1.27M
AMED
36
DELISTED
Amedisys
AMED
$3.08M 1.05%
55,000
+10,393
+23% +$550K
ILMN icon
37
Illumina
ILMN
$29B
$2.99M 1.02%
15,420
+5,140
+50% +$957K
ZBH icon
38
Zimmer Biomet
ZBH
$18.7B
$2.93M 1%
+25,750
New +$2.97M
IDXX icon
39
Idexx Laboratories
IDXX
$46.9B
$2.72M 0.93%
+17,500
New +$2.77M
TECH icon
40
Bio-Techne
TECH
$11.2B
$2.58M 0.88%
+85,356
New +$2.53M
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.54M 0.86%
25,000
-5,000
-17% -$535K
CHE icon
42
Chemed
CHE
$7.18B
$2.53M 0.86%
12,500
– –
BHC icon
43
Bausch Health
BHC
$2.37B
$2.51M 0.85%
175,000
-70,000
-29% -$1.06M
ALGN icon
44
Align Technology
ALGN
$12.5B
$2.5M 0.85%
+13,400
New +$2.29M
CLVS
45
DELISTED
Clovis Oncology, Inc.
CLVS
$2.47M 0.84%
30,000
+10,000
+50% +$793K
JUNO
46
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.47M 0.84%
+55,000
New +$1.88M
BLUE
47
DELISTED
bluebird bio
BLUE
$2.4M 0.82%
1,351
+193
+17% +$270K
PBYI icon
48
Puma Biotechnology
PBYI
$442M
$2.4M 0.81%
20,000
– –
EHC icon
49
Encompass Health
EHC
$12.5B
$2.36M 0.8%
+63,996
New +$2.28M
LOXO
50
DELISTED
Loxo Oncology, Inc
LOXO
$2.3M 0.78%
25,000
+4,500
+22% +$350K
1
2
3 4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q3 2017 Portfolio in Review

As of Q3 2017, Sivik Global Healthcare held 92 positions worth $294M, up 7.6% from $273M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare's Q3 2017 filing shows 25 new, 25 increased, 19 reduced and 18 closed positions. Its largest new stake was Danaher: 62,040 shares worth $4.72M. The largest sale was Johnson & Johnson, an estimated $9.28M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 88% a quarter earlier, followed by Financials and Energy.

  • Sivik Global Healthcare's largest Q3 2017 buy was Danaher: 62,040 shares worth $4.72M.
  • Sivik Global Healthcare added most to Thermo Fisher Scientific in Q3 2017, an estimated $3.62M increase.
  • Sivik Global Healthcare's biggest Q3 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $6.79M.
  • Sivik Global Healthcare fully exited Johnson & Johnson in Q3 2017, selling an estimated $9.28M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $294M portfolio in Q3 2017.
  • Sivik Global Healthcare opened 25 new positions and closed 18 in Q3 2017.
  • Sivik Global Healthcare's portfolio value rose 7.6% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q3 2017, filed 8 Nov 2017.